A NEW Australian technology is set to transform gastrointestinal cancer detection and treatment through precise, minimally invasive surgery. Backed by a $405,050 Federal Government AEA Ignite Grant, UniSA researchers, led by Dr Nicole Dmochowska, are developing a quantum-based laparoscopic probe.
In partnership with Ferronova, the probe works with iron-oxide nanoparticles (FerroTrace) to improve detection of cancerous lymph nodes, reducing the need for extensive surgery that can cause serious complications and long-term side effects.
Gastrointestinal cancers often spread via the lymphatic system before diagnosis, and traditional surgery involves removing large tissue sections, increasing infection and digestive risks.
The UniSA team has successfully demonstrated this technology in a phase-1 oral cancer trial. The magnetometer-based probe has been in development for over eight years, and preclinical trials for gastrointestinal cancers are expected to begin within the next year.